title: Characterization of the binding sites for dicarboxylic acids on bovine serum albumin.
abstract: Dicarboxylic acids are prominent features of several diseases, including Reye's syndrome and inborn errors of mitochondrial and peroxisomal fatty acid oxidation. Moreover, dicarboxylic acids are potentially toxic to cellular processes. Previous studies [Tonsgard, Mendelson & Meredith (1988) J. Clin. Invest. 82, 1567-1573] demonstrated that long-chain dicarboxylic acids have a single high-affinity binding site and between one and three lower-affinity sites on albumin. Medium-chain-length dicarboxylic acids have a single low-affinity site. We further characterized dicarboxylic acid binding to albumin in order to understand the potential effects of drugs and other ligands on dicarboxylic acid binding and toxicity. Progesterone and oleate competitively inhibit octadecanedioic acid binding to the single high-affinity site. Octanoate inhibits binding to the low-affinity sites. Dansylated probes for subdomain 2AB inhibit dodecanedioic acid binding whereas probes for subdomain 3AB do not. In contrast, low concentrations of octadecanedioic acid inhibit the binding of dansylated probes to subdomain 3AB and 2AB. L-Tryptophan, which binds in subdomain 3AB, inhibits hexadecanedioic acid binding but has no effect on dodecanedioic acid. Bilirubin and acetylsalicylic acid, which bind in subdomain 2AB, inhibit the binding of medium-chain and long-chain dicarboxylic acids. Our results suggest that long-chain dicarboxylic acids bind in subdomains 2C, 3AB and 2AB. The single low-affinity binding site for medium-chain dicarboxylic acids is in subdomain 2AB. These studies suggest that dicarboxylic acids are likely to be unbound in disease states and may be potentially toxic.
authors.affiliation: Department of Pediatrics, Pritzker Medical School, University of Chicago, IL 60637.
authors.forename: J H
authors.initials: JH
authors.lastname: Tonsgard
authors.forename: S C
authors.initials: SC
authors.lastname: Meredith
mesh_terms: D000215:Acylation; D001241:Aspirin / Q000494:pharmacology; D001667:Binding, Competitive / Q000187:drug effects; D003998:Dicarboxylic Acids / Q000737:chemistry / Q000378:metabolism*; D007848:Laurates / Q000378:metabolism; D008958:Models, Molecular; D011374:Progesterone / Q000378:metabolism; D011955:Receptors, Drug / Q000737:chemistry*; D012710:Serum Albumin, Bovine / Q000737:chemistry / Q000378:metabolism*; D013438:Sulfhydryl Compounds / Q000737:chemistry
chemical_list: D003998:Dicarboxylic Acids; D007848:Laurates; D011955:Receptors, Drug; D013438:Sulfhydryl Compounds; D012710:Serum Albumin, Bovine; D011374:Progesterone; D001241:Aspirin